PILA PHARMA
Entity

  • PILA PHARMA

    Created in 2014


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    1,938

  • Activities

    biotech deeptech

  • Entity types

    Startup

  • Location

    Västergatan 1, 211 21 Malmö, Sweden

    Malmö

    Sweden

  • Employees

    Scale: 2-10

    Estimated: 9

  • Engaged catalyst

    2
    0 0

  • Added in Motherbase

    7 months ago
Description
  • Value proposition

    We are a #TRPV1 focused company developing oral treatments for Type-2 #Diabetes & #Erythromelalgia

    PILA PHARMA is a publicly held clinical stage pharmaceutical company based in Malmö, Sweden.

    PILA PHARMA is developing a novel type of oral anti-diabetic agent: a TRPV1 antagonist for the treatment of diabetes.

  • Pila Pharma

    Pila Pharma AB, a clinical stage biotech company listed on Nasdaq First North GM in Stockholm, Sweden, is pioneering the development of XEN-D0501, a novel TRPV1 antagonist aimed at revolutionizing diabetes and obesity treatment. Explore our journey as we prepare for a phase 2a clinical trial to evaluate XEN-D0501's safety and potential effects on blood glucose and body weight in overweight or obese individuals with diabetes. | About PILA PHARMA

    • https://pilapharma.com/
Catalyst interactions
Catalyst TypeTweets Articles
Business Sweden
Business Sweden
Business Consulting and Services
Business Sweden
Business Consulting and Services 		Other

14 May 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing 		Other

31 Dec 2024


Social network dynamics
Last news
Show all articles